Bortezomib for Injection

Bortezomib for injection is a medication used in the treatment of certain types of cancer, primarily multiple myeloma and mantle cell lymphoma. It belongs to a class of drugs called proteasome inhibitors.

This medication works by interfering with the growth and spread of cancer cells. It inhibits proteasomes, which are structures within cells that break down proteins. By blocking these proteasomes, bortezomib disrupts the normal processes within cancer cells, ultimately leading to their death.